# Effect of Subconjunctival 5-fluorouracil on the Outcome of Ahmed Valve in Neovascular Glaucoma

> **NCT05316142** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Iran University of Medical Sciences** · enrollment: 70 (estimated)

## Conditions studied

- Neovascular Glaucoma

## Interventions

- **PROCEDURE:** AGV with intraoperation MMC and postoperative BSS
- **PROCEDURE:** AGV with intraoperation MMC and post operation 5FU

## Key facts

- **NCT ID:** NCT05316142
- **Lead sponsor:** Iran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-05-01
- **Primary completion:** 2025-12-01
- **Final completion:** 2025-12-01
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2025-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05316142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05316142, "Effect of Subconjunctival 5-fluorouracil on the Outcome of Ahmed Valve in Neovascular Glaucoma". Retrieved via AI Analytics 2026-08-24 from https://api.ai-analytics.org/clinical/NCT05316142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*